... in calvarial periosteum and less so in neck muscles and fascia. migraine occipital neuralgia botox trigeminal pain National Institutes of Health 10.13039/100000002 R37 NS079678 RO1 NS094198 RO1 NS106345 Occipital headache, the perception of pain in the back of the head, is commonly described...

... between 1970 and 2019 (with one article from 1897). Relevant articles referenced within these texts were also included. One article did not have an accompanied English full-text available. The following search terms were used: “Botox”, “Botulinum toxin”, “Botulinum toxin A”, “Onabotulinum A”, “Abobutlinum...

.... Methods A PubMed search for English-language articles was performed using the following terms: “Botox,” “botulinum toxin,” “botulinum toxin A,” “Onabotulinum A,” “Abobutlinum A,” “BoNT,” and “BoNT-A.” The main outcomes measured by each study were resolution of dysfunction. This entailed reduction of pain...

... muscles. ¹³ BoNT-A is the most commonly used serotype for medical application and was the first to be licensed for medical use. There are several commercially available forms; Botox (Allergan Pharmaceuticals, Parsippany, NJ, USA) is the most widely used and has the most medical applications...

...Aziz Khambati; Susan Lau; Allan Gordon; Keith A. Jarvi Botox Chronic Scrotal Pain OnabotulinumtoxinA Abstract Introduction Chronic scrotal pain (CSP) is a common, often debilitating, condition affecting approximately 4.75% of men. While nerve blocks using local anesthetics usually provide...

..., this is the first report of an allergy to onabotulinumtoxinA. The 43-year-old woman experienced severe itching after injection of Botox and Juvéderm. Results of prick and patch testing confirmed a T-cell–mediated allergy to Botox. This case can aid in the evaluation of suspected allergies to Botox. Level...

.... Level of Evidence: 3 cosmetic medicine gummy smile gingival exposure onabotulinumtoxinA Botox levator labii superioris levator labii superioris alaeque nasi hyperfunctional lip elevators The authors of this article discuss an application of onabotulinumtoxinA that is currently off-label...

.... Adverse events from abobotulinumtoxinA are similar to those reported with other BoNTA products. Clinical applications of the product are also discussed in this article. Information on handling, storage, and dosing is provided. facial aesthetics glabellar lines neuromodulators neurotoxins Botox...

.... Finally, incobotulinumtoxinA's mechanism of action is described. facial aesthetics glabellar lines neuromodulators neurotoxins Botox onabotulinumtoxinA Dysport abobotulinumtoxinA Xeomin incobotulinumtoxinA botulinum neurotoxin type A IncobotulinumtoxinA contains only 0.44 ng of neurotoxin...

... concentration, stability and dissociation, and endopeptide immunoassay. facial aesthetics glabellar lines neuromodulators neurotoxins Botox onabotulinumtoxinA Dysport abobotulinumtoxinA Xeomin incobotulinumtoxinA botulinum neurotoxin type A Figure 1. Five injection sites for studies...

... of complexing proteins, and dosing and injection strategies. Recommendations are also provided by treatment area. facial aesthetics glabellar lines neuromodulators neurotoxins Botox onabotulinumtoxinA Dysport abobotulinumtoxinA Xeomin incobotulinumtoxinA botulinum neurotoxin type A Although previous...

... data. As with other BoNTA products, onabotulinumtoxinA is generally well tolerated. Consideration is also given to clinical applications of the product. Information on handling, storage, and dosing is provided. facial aesthetics glabellar lines neuromodulators neurotoxins Botox onabotulinumtoxinA...

... the level of esophageal dilation and the pressure target for EGJ disruption for flow to occur. Combining these parameters allows for a mechanistically driven classification with a focus on predicting clinical outcome. ¹⁷ achalasia high resolution manometry Heller myotomy BoTox injection...

... molecular weights. ³² International studies of serotype A (BTX-A) in the form of Botox (Allergan, Inc., Irvine, California) or Dysport (Ipsen, Brisbane, California) ³³ have demonstrated its safety and efficacy for numerous indications. Both products are based on the BTX-A serotype...

... commercially available neurotoxins to improve facial aesthetics, but few prospective, randomized trials have been conducted without commercial support to compare these agents. Objectives: The authors present the results of a study examining and comparing the effects of onabotulinumtoxinA (BoNT-ONA; Botox...

... cited decreased BTX-A efficacy as the reason for their preference. Conclusions: Vibration is a safe and effective means of reducing patient discomfort during BTX-A injections for cosmetic rhytid reduction and may have applications in other cosmetic procedures. Botox cosmetic injectables rhytids...

... offers multiple clinical benefits over standard skin care, including significantly greater improvements in fine lines/wrinkles and hyperpigmentation. Level of Evidence : 2 Botox botulinum toxin Type A hydroquinone skin care tretinoin facial rejuvenation A 4% hydroquinone skin care system has been...

.... Abstract Objective. To examine pain relief in patients with neurogenic thoracic outlet syndrome (NTOS) after a single, low dose injection of botulinum toxin A (Botox) into the anterior scalene muscle (ASM) under computed tomographic (CT) guidance. Design. Prospective longitudinal study. Setting...

.../open_access/funder_policies/chorus/standard_publication_model ) Injection was performed as an office procedure. BOTOX powder (botulinum toxin Type A, by Allergan Pharmaceuticals; Irvine, CA, USA) was reconstituted in 0.9% sterile, nonpreserved saline (100 units [U] in 2.5 mL saline). Penile shaft was scrubbed...

... Compensatory sweating BTX-A botox Sympathectomy Sufferers of this debilitating illness are frequently embarrassed by their ‘wet’ handshake and sweat stained clothes, often leading to significant psychological and social morbidity. Treatment initially consists of topical applications of antiperspirants...